Study found insulin nasal spray may fight memory loss in Alzheimer’s patients
WASHINGTON, D.C. – A recent study funded by the National Institutes for Health (NIH) found that people suffering from Alzheimer’s showed memory improvement after receiving a daily dose of a nasal insulin spray. George Vradenburg, Founder and Chairman of USAgainstAlzheimer’s, and a recent appointee to the National Alzheimer’s Project Act’s (NAPA) Advisory Council on Alzheimer’s Research, Care, and Services, released the following statement today in response to the study’s findings.
"This discovery is another intriguing sign that American researchers are finding paths to potential Alzheimer’s treatments, and underscores the urgent need to put the 'pedal to the medal' to accelerate smart, innovative, 21st century approaches to Alzheimer's research and drug discovery – all with the goal of saving American lives and reducing the rapidly-escalating costs of care to American families and taxpayers. Of the 10 leading causes of death in the U.S., Alzheimer’s is the only disease that has no known treatment or cure. Despite this, NIH only invests about $450 million per year on Alzheimer’s research while the costs for caring for those with the disease exceeds $183 billion annually.
"USAgainstAlzheimer’s shares the belief of the research community that we can defeat this disease by 2020 through innovative public-private partnerships, cutting the costs and time-to-market for new drugs, and more strategic funding for research.
"America requires a comprehensive, funded national Alzheimer's plan with clear goals, timetables and accountability. The time to act is now."